Reaction Details |
| Report a problem with these data |
Target | Alpha-synuclein |
---|
Ligand | BDBM207866 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | In Vitro Inhibition Assay |
---|
EC50 | 94±n/a nM |
---|
Citation | Griffioen, G; Van Dooren, T; Rojas De La Parra, V; Allasia, S; Marchand, A; Kilonda, A; Chaltin, P Compounds for the treatment of neurodegenerative diseases US Patent US9266832 Publication Date 2/23/2016 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Alpha-synuclein |
---|
Name: | Alpha-synuclein |
Synonyms: | NACP | PARK1 | SNCA | SYUA_HUMAN |
Type: | Protein |
Mol. Mass.: | 14451.42 |
Organism: | Homo sapiens (Human) |
Description: | P37840 |
Residue: | 140 |
Sequence: | MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTK
EQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDP
DNEAYEMPSEEGYQDYEPEA
|
|
|
BDBM207866 |
---|
n/a |
---|
Name | BDBM207866 |
Synonyms: | US9266832, Cpd023 |
Type | Small organic molecule |
Emp. Form. | C25H24ClN3O |
Mol. Mass. | 417.931 |
SMILES | Clc1ccc2[nH]cc(CCNC(=O)c3cccc(CNCc4ccccc4)c3)c2c1 |
Structure |
|